Affordable Access

Access to the full text

Associations between gut microbiota and Alzheimer’s disease, major depressive disorder, and schizophrenia

Authors
  • Zhuang, Zhenhuang1
  • Yang, Ruotong1
  • Wang, Wenxiu1
  • Qi, Lu2, 3
  • Huang, Tao1, 4, 5, 4
  • 1 Peking University, 38 Xueyuan Road, Beijing, 100191, China , Beijing (China)
  • 2 Tulane University, New Orleans, LA, USA , New Orleans (United States)
  • 3 Harvard T.H. Chan School of Public Health, Boston, MA, USA , Boston (United States)
  • 4 Peking University, Beijing, 100191, China , Beijing (China)
  • 5 Ministry of Education, Beijing, 100191, China , Beijing (China)
Type
Published Article
Journal
Journal of Neuroinflammation
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Oct 02, 2020
Volume
17
Issue
1
Identifiers
DOI: 10.1186/s12974-020-01961-8
Source
Springer Nature
Keywords
License
Green

Abstract

BackgroundGrowing evidence has shown that alterations in the gut microbiota composition were associated with a variety of neuropsychiatric conditions. However, whether such associations reflect causality remains unknown. We aimed to reveal the causal relationships among gut microbiota, metabolites, and neuropsychiatric disorders including Alzheimer’s disease (AD), major depressive disorder (MDD), and schizophrenia (SCZ).MethodsA two-sample bi-directional Mendelian randomization analysis was performed by using genetic variants from genome-wide association studies as instrumental variables for gut microbiota, metabolites, AD, MDD, and SCZ, respectively.ResultsWe found suggestive associations of host-genetic-driven increase in Blautia (OR, 0.88; 95%CI, 0.79–0.99; P = 0.028) and elevated γ-aminobutyric acid (GABA) (0.96; 0.92–1.00; P = 0.034), a downstream product of Blautia-dependent arginine metabolism, with a lower risk of AD. Genetically increased Enterobacteriaceae family and Enterobacteriales order were potentially associated with a higher risk of SCZ (1.09; 1.00–1.18; P = 0.048), while Gammaproteobacteria class (0.90; 0.83–0.98; P = 0.011) was related to a lower risk for SCZ. Gut production of serotonin was potentially associated with an increased risk of SCZ (1.07; 1.00–1.15; P = 0.047). Furthermore, genetically increased Bacilli class was related to a higher risk of MDD (1.07; 1.02–1.12; P = 0.010). In the other direction, neuropsychiatric disorders altered gut microbiota composition.ConclusionsThese data for the first time provide evidence of potential causal links between gut microbiome and AD, MDD, and SCZ. GABA and serotonin may play an important role in gut microbiota-host crosstalk in AD and SCZ, respectively. Further investigations in understanding the underlying mechanisms of associations between gut microbiota and AD, MDD, and SCZ are required.

Report this publication

Statistics

Seen <100 times